相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide
M. E. van Muijen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2022)
Dose spacing and reduction strategies in biotherapies for stable, clear or almost clear psoriasis: A survey of practices in France
H. Aubert et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2022)
Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey
April Armstrong et al.
DERMATOLOGY AND THERAPY (2022)
Patient-Relevant Outcomes in Psoriasis A Systematic Review
Niels Hilhorst et al.
JAMA DERMATOLOGY (2022)
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
C. A. J. Michielsens et al.
DRUGS (2021)
Research Techniques Made Simple: An Introduction to Qualitative Research
Alexus Bazen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice
Selma Atalay et al.
ACTA DERMATO-VENEREOLOGICA (2021)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A changed life: the life experiences of patients with psoriasis receiving biological treatment
B. Trettin et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Treatment goals in psoriasis from a patient perspective: a qualitative study
Tessa A. Kouwenhoven et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2020)
Comparison of Biologics and Oral Treatments for Plaque Psoriasis A Meta-analysis
April W. Armstrong et al.
JAMA DERMATOLOGY (2020)
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis A Randomized Clinical Trial
Selma Atalay et al.
JAMA DERMATOLOGY (2020)
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
Selma Atalay et al.
ACTA DERMATO-VENEREOLOGICA (2020)
Tapering Biologic Therapy for Rheumatoid Arthritis: A Qualitative Study of Patient Perspectives
Suz Jack Chan et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2020)
Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?
D. Wallis et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2019)
Dose reduction of biologic therapy in inflammatory arthritis: A qualitative study of patients' perceptions and needs
Sarah Hewlett et al.
MUSCULOSKELETAL CARE (2019)
regThe patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study
Lise M. Verhoef et al.
RHEUMATOLOGY (2018)
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
J. M. P. A. van den Reek et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients' opinion
I. M. Markusse et al.
CLINICAL RHEUMATOLOGY (2014)
A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice
Signe A. Flottorp et al.
IMPLEMENTATION SCIENCE (2013)
Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course
R. B. Warren et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Psoriasis: is the impairment to a patient's life cumulative?
A. B. Kimball et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
分享论文
